Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
![Diagram of MOR-1 (mu-opioid receptor) splicing and alternative splicing... | Download Scientific Diagram Diagram of MOR-1 (mu-opioid receptor) splicing and alternative splicing... | Download Scientific Diagram](https://www.researchgate.net/publication/221720898/figure/fig3/AS:267618439397424@1440816616498/Diagram-of-MOR-1-mu-opioid-receptor-splicing-and-alternative-splicing-adapted-from.png)
Diagram of MOR-1 (mu-opioid receptor) splicing and alternative splicing... | Download Scientific Diagram
![PDF] Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | Semantic Scholar PDF] Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/70ff2fcd2e721db6c8b35cc227c4ea5d3c9674cb/3-Table1-1.png)
PDF] Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | Semantic Scholar
![A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422006870-gr1.jpg)
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
![Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management - Pergolizzi - 2020 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management - Pergolizzi - 2020 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0ebcd542-a70c-444c-95a4-ba4e2401a86e/jcpt13114-fig-0003-m.jpg)
Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management - Pergolizzi - 2020 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
![Pharmaceutics | Free Full-Text | Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism Pharmaceutics | Free Full-Text | Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-01466/article_deploy/html/images/pharmaceutics-13-01466-g001.png)
Pharmaceutics | Free Full-Text | Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE
![Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management | Journal of Medicinal Chemistry Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00611/asset/images/large/jm1c00611_0023.jpeg)